1 Nanostructured Drug Market Overview 1.1 Nanostructured Drug Product Scope 1.2 Nanostructured Drug Segment by Type 1.2.1 Global Nanostructured Drug Sales by Type (2017 & 2021 & 2028) 1.2.2 Liposomes 1.2.3 Polymeric Micelles 1.2.4 Solid lipid Nanoparticles 1.2.5 Microemulsion and Nanoemulsion 1.2.6 Nanosuspension 1.3 Nanostructured Drug Segment by Application 1.3.1 Global Nanostructured Drug Sales Comparison by Application (2017 & 2021 & 2028) 1.3.2 Cancer and Tumors 1.3.3 Autoimmune Disorders 1.4 Nanostructured Drug Market Estimates and Forecasts (2017-2028) 1.4.1 Global Nanostructured Drug Market Size in Value Growth Rate (2017-2028) 1.4.2 Global Nanostructured Drug Market Size in Volume Growth Rate (2017-2028) 1.4.3 Global Nanostructured Drug Price Trends (2017-2028) 2 Nanostructured Drug Estimates and Forecasts by Region 2.1 Global Nanostructured Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2 Global Nanostructured Drug Retrospective Market Scenario by Region (2017-2022) 2.2.1 Global Nanostructured Drug Sales Market Share by Region (2017-2022) 2.2.2 Global Nanostructured Drug Revenue Market Share by Region (2017-2022) 2.3 Global Nanostructured Drug Market Estimates and Forecasts by Region (2023-2028) 2.3.1 Global Nanostructured Drug Sales Estimates and Forecasts by Region (2023-2028) 2.3.2 Global Nanostructured Drug Revenue Forecast by Region (2023-2028) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Nanostructured Drug Estimates and Projections (2017-2028) 2.4.2 Europe Nanostructured Drug Estimates and Projections (2017-2028) 2.4.3 China Nanostructured Drug Estimates and Projections (2017-2028) 2.4.4 Japan Nanostructured Drug Estimates and Projections (2017-2028) 2.4.5 Southeast Asia Nanostructured Drug Estimates and Projections (2017-2028) 2.4.6 India Nanostructured Drug Estimates and Projections (2017-2028) 3 Global Nanostructured Drug Competition Landscape by Players 3.1 Global Top Nanostructured Drug Players by Sales (2017-2022) 3.2 Global Top Nanostructured Drug Players by Revenue (2017-2022) 3.3 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanostructured Drug as of 2021) 3.4 Global Nanostructured Drug Average Price by Company (2017-2022) 3.5 Manufacturers Nanostructured Drug Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Nanostructured Drug Market Size by Type 4.1 Global Nanostructured Drug Historic Market Review by Type (2017-2022) 4.1.1 Global Nanostructured Drug Sales Market Share by Type (2017-2022) 4.1.2 Global Nanostructured Drug Revenue Market Share by Type (2017-2022) 4.1.3 Global Nanostructured Drug Price by Type (2017-2022) 4.2 Global Nanostructured Drug Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Nanostructured Drug Sales Forecast by Type (2023-2028) 4.2.2 Global Nanostructured Drug Revenue Forecast by Type (2023-2028) 4.2.3 Global Nanostructured Drug Price Forecast by Type (2023-2028) 5 Global Nanostructured Drug Market Size by Application 5.1 Global Nanostructured Drug Historic Market Review by Application (2017-2022) 5.1.1 Global Nanostructured Drug Sales Market Share by Application (2017-2022) 5.1.2 Global Nanostructured Drug Revenue Market Share by Application (2017-2022) 5.1.3 Global Nanostructured Drug Price by Application (2017-2022) 5.2 Global Nanostructured Drug Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Nanostructured Drug Sales Forecast by Application (2023-2028) 5.2.2 Global Nanostructured Drug Revenue Forecast by Application (2023-2028) 5.2.3 Global Nanostructured Drug Price Forecast by Application (2023-2028) 6 United States Nanostructured Drug Market Facts & Figures 6.1 United States Nanostructured Drug Sales by Company 6.1.1 United States Nanostructured Drug Sales by Company (2017-2022) 6.1.2 United States Nanostructured Drug Revenue by Company (2017-2022) 6.2 United States Nanostructured Drug Sales Breakdown by Type 6.2.1 United States Nanostructured Drug Sales Breakdown by Type (2017-2022) 6.2.2 United States Nanostructured Drug Sales Breakdown by Type (2023-2028) 6.3 United States Nanostructured Drug Sales Breakdown by Application 6.3.1 United States Nanostructured Drug Sales Breakdown by Application (2017-2022) 6.3.2 United States Nanostructured Drug Sales Breakdown by Application (2023-2028) 7 Europe Nanostructured Drug Market Facts & Figures 7.1 Europe Nanostructured Drug Sales by Company 7.1.1 Europe Nanostructured Drug Sales by Company (2017-2022) 7.1.2 Europe Nanostructured Drug Revenue by Company (2017-2022) 7.2 Europe Nanostructured Drug Sales Breakdown by Type 7.2.1 Europe Nanostructured Drug Sales Breakdown by Type (2017-2022) 7.2.2 Europe Nanostructured Drug Sales Breakdown by Type (2023-2028) 7.3 Europe Nanostructured Drug Sales Breakdown by Application 7.3.1 Europe Nanostructured Drug Sales Breakdown by Application (2017-2022) 7.3.2 Europe Nanostructured Drug Sales Breakdown by Application (2023-2028) 8 China Nanostructured Drug Market Facts & Figures 8.1 China Nanostructured Drug Sales by Company 8.1.1 China Nanostructured Drug Sales by Company (2017-2022) 8.1.2 China Nanostructured Drug Revenue by Company (2017-2022) 8.2 China Nanostructured Drug Sales Breakdown by Type 8.2.1 China Nanostructured Drug Sales Breakdown by Type (2017-2022) 8.2.2 China Nanostructured Drug Sales Breakdown by Type (2023-2028) 8.3 China Nanostructured Drug Sales Breakdown by Application 8.3.1 China Nanostructured Drug Sales Breakdown by Application (2017-2022) 8.3.2 China Nanostructured Drug Sales Breakdown by Application (2023-2028) 9 Japan Nanostructured Drug Market Facts & Figures 9.1 Japan Nanostructured Drug Sales by Company 9.1.1 Japan Nanostructured Drug Sales by Company (2017-2022) 9.1.2 Japan Nanostructured Drug Revenue by Company (2017-2022) 9.2 Japan Nanostructured Drug Sales Breakdown by Type 9.2.1 Japan Nanostructured Drug Sales Breakdown by Type (2017-2022) 9.2.2 Japan Nanostructured Drug Sales Breakdown by Type (2023-2028) 9.3 Japan Nanostructured Drug Sales Breakdown by Application 9.3.1 Japan Nanostructured Drug Sales Breakdown by Application (2017-2022) 9.3.2 Japan Nanostructured Drug Sales Breakdown by Application (2023-2028) 10 Southeast Asia Nanostructured Drug Market Facts & Figures 10.1 Southeast Asia Nanostructured Drug Sales by Company 10.1.1 Southeast Asia Nanostructured Drug Sales by Company (2017-2022) 10.1.2 Southeast Asia Nanostructured Drug Revenue by Company (2017-2022) 10.2 Southeast Asia Nanostructured Drug Sales Breakdown by Type 10.2.1 Southeast Asia Nanostructured Drug Sales Breakdown by Type (2017-2022) 10.2.2 Southeast Asia Nanostructured Drug Sales Breakdown by Type (2023-2028) 10.3 Southeast Asia Nanostructured Drug Sales Breakdown by Application 10.3.1 Southeast Asia Nanostructured Drug Sales Breakdown by Application (2017-2022) 10.3.2 Southeast Asia Nanostructured Drug Sales Breakdown by Application (2023-2028) 11 India Nanostructured Drug Market Facts & Figures 11.1 India Nanostructured Drug Sales by Company 11.1.1 India Nanostructured Drug Sales by Company (2017-2022) 11.1.2 India Nanostructured Drug Revenue by Company (2017-2022) 11.2 India Nanostructured Drug Sales Breakdown by Type 11.2.1 India Nanostructured Drug Sales Breakdown by Type (2017-2022) 11.2.2 India Nanostructured Drug Sales Breakdown by Type (2023-2028) 11.3 India Nanostructured Drug Sales Breakdown by Application 11.3.1 India Nanostructured Drug Sales Breakdown by Application (2017-2022) 11.3.2 India Nanostructured Drug Sales Breakdown by Application (2023-2028) 12 Company Profiles and Key Figures in Nanostructured Drug Business 12.1 Merck 12.1.1 Merck Corporation Information 12.1.2 Merck Business Overview 12.1.3 Merck Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.1.4 Merck Nanostructured Drug Products Offered 12.1.5 Merck Recent Development 12.2 Pfizer 12.2.1 Pfizer Corporation Information 12.2.2 Pfizer Business Overview 12.2.3 Pfizer Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.2.4 Pfizer Nanostructured Drug Products Offered 12.2.5 Pfizer Recent Development 12.3 Novartis 12.3.1 Novartis Corporation Information 12.3.2 Novartis Business Overview 12.3.3 Novartis Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.3.4 Novartis Nanostructured Drug Products Offered 12.3.5 Novartis Recent Development 12.4 Abbott 12.4.1 Abbott Corporation Information 12.4.2 Abbott Business Overview 12.4.3 Abbott Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.4.4 Abbott Nanostructured Drug Products Offered 12.4.5 Abbott Recent Development 12.5 GlaxoSmithKline 12.5.1 GlaxoSmithKline Corporation Information 12.5.2 GlaxoSmithKline Business Overview 12.5.3 GlaxoSmithKline Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.5.4 GlaxoSmithKline Nanostructured Drug Products Offered 12.5.5 GlaxoSmithKline Recent Development 12.6 Roche 12.6.1 Roche Corporation Information 12.6.2 Roche Business Overview 12.6.3 Roche Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.6.4 Roche Nanostructured Drug Products Offered 12.6.5 Roche Recent Development 12.7 Sanofi 12.7.1 Sanofi Corporation Information 12.7.2 Sanofi Business Overview 12.7.3 Sanofi Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.7.4 Sanofi Nanostructured Drug Products Offered 12.7.5 Sanofi Recent Development 12.8 Eli Lilly 12.8.1 Eli Lilly Corporation Information 12.8.2 Eli Lilly Business Overview 12.8.3 Eli Lilly Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.8.4 Eli Lilly Nanostructured Drug Products Offered 12.8.5 Eli Lilly Recent Development 12.9 Astrazeneca 12.9.1 Astrazeneca Corporation Information 12.9.2 Astrazeneca Business Overview 12.9.3 Astrazeneca Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.9.4 Astrazeneca Nanostructured Drug Products Offered 12.9.5 Astrazeneca Recent Development 12.10 Johnson & Johnson 12.10.1 Johnson & Johnson Corporation Information 12.10.2 Johnson & Johnson Business Overview 12.10.3 Johnson & Johnson Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.10.4 Johnson & Johnson Nanostructured Drug Products Offered 12.10.5 Johnson & Johnson Recent Development 12.11 Celgene 12.11.1 Celgene Corporation Information 12.11.2 Celgene Business Overview 12.11.3 Celgene Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.11.4 Celgene Nanostructured Drug Products Offered 12.11.5 Celgene Recent Development 12.12 Novavax 12.12.1 Novavax Corporation Information 12.12.2 Novavax Business Overview 12.12.3 Novavax Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.12.4 Novavax Nanostructured Drug Products Offered 12.12.5 Novavax Recent Development 12.13 Stryker 12.13.1 Stryker Corporation Information 12.13.2 Stryker Business Overview 12.13.3 Stryker Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.13.4 Stryker Nanostructured Drug Products Offered 12.13.5 Stryker Recent Development 12.14 Gilead Sciences 12.14.1 Gilead Sciences Corporation Information 12.14.2 Gilead Sciences Business Overview 12.14.3 Gilead Sciences Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.14.4 Gilead Sciences Nanostructured Drug Products Offered 12.14.5 Gilead Sciences Recent Development 12.15 OSI Pharmaceuticals 12.15.1 OSI Pharmaceuticals Corporation Information 12.15.2 OSI Pharmaceuticals Business Overview 12.15.3 OSI Pharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.15.4 OSI Pharmaceuticals Nanostructured Drug Products Offered 12.15.5 OSI Pharmaceuticals Recent Development 12.16 Kadmon Pharmaceuticals 12.16.1 Kadmon Pharmaceuticals Corporation Information 12.16.2 Kadmon Pharmaceuticals Business Overview 12.16.3 Kadmon Pharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.16.4 Kadmon Pharmaceuticals Nanostructured Drug Products Offered 12.16.5 Kadmon Pharmaceuticals Recent Development 12.17 Samyang Biopharm 12.17.1 Samyang Biopharm Corporation Information 12.17.2 Samyang Biopharm Business Overview 12.17.3 Samyang Biopharm Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.17.4 Samyang Biopharm Nanostructured Drug Products Offered 12.17.5 Samyang Biopharm Recent Development 12.18 Mitsubishi Pharma 12.18.1 Mitsubishi Pharma Corporation Information 12.18.2 Mitsubishi Pharma Business Overview 12.18.3 Mitsubishi Pharma Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.18.4 Mitsubishi Pharma Nanostructured Drug Products Offered 12.18.5 Mitsubishi Pharma Recent Development 12.19 Kaken Pharmaceutical 12.19.1 Kaken Pharmaceutical Corporation Information 12.19.2 Kaken Pharmaceutical Business Overview 12.19.3 Kaken Pharmaceutical Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.19.4 Kaken Pharmaceutical Nanostructured Drug Products Offered 12.19.5 Kaken Pharmaceutical Recent Development 12.20 Selecta Biosciences 12.20.1 Selecta Biosciences Corporation Information 12.20.2 Selecta Biosciences Business Overview 12.20.3 Selecta Biosciences Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.20.4 Selecta Biosciences Nanostructured Drug Products Offered 12.20.5 Selecta Biosciences Recent Development 12.21 Par Pharmaceutical 12.21.1 Par Pharmaceutical Corporation Information 12.21.2 Par Pharmaceutical Business Overview 12.21.3 Par Pharmaceutical Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.21.4 Par Pharmaceutical Nanostructured Drug Products Offered 12.21.5 Par Pharmaceutical Recent Development 12.22 Cerulean Pharma 12.22.1 Cerulean Pharma Corporation Information 12.22.2 Cerulean Pharma Business Overview 12.22.3 Cerulean Pharma Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.22.4 Cerulean Pharma Nanostructured Drug Products Offered 12.22.5 Cerulean Pharma Recent Development 12.23 Navidea Biopharmaceuticals 12.23.1 Navidea Biopharmaceuticals Corporation Information 12.23.2 Navidea Biopharmaceuticals Business Overview 12.23.3 Navidea Biopharmaceuticals Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.23.4 Navidea Biopharmaceuticals Nanostructured Drug Products Offered 12.23.5 Navidea Biopharmaceuticals Recent Development 12.24 Lummy 12.24.1 Lummy Corporation Information 12.24.2 Lummy Business Overview 12.24.3 Lummy Nanostructured Drug Sales, Revenue and Gross Margin (2017-2022) 12.24.4 Lummy Nanostructured Drug Products Offered 12.24.5 Lummy Recent Development 13 Nanostructured Drug Manufacturing Cost Analysis 13.1 Nanostructured Drug Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Nanostructured Drug 13.4 Nanostructured Drug Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Nanostructured Drug Distributors List 14.3 Nanostructured Drug Customers 15 Market Dynamics 15.1 Nanostructured Drug Industry Trends 15.2 Nanostructured Drug Market Drivers 15.3 Nanostructured Drug Market Challenges 15.4 Nanostructured Drug Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Nanostructured Drug Sales (US$ Million) Growth Rate by Type (2017 & 2021 & 2028) Table 2. Global Nanostructured Drug Sales ((US$ Million)) Comparison by Application (2017 & 2021 & 2028) Table 3. Global Nanostructured Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 4. Global Nanostructured Drug Sales (K MT) by Region (2017-2022) Table 5. Global Nanostructured Drug Sales Market Share by Region (2017-2022) Table 6. Global Nanostructured Drug Revenue (US$ Million) Market Share by Region (2017-2022)) Table 7. Global Nanostructured Drug Revenue Share by Region (2017-2022) Table 8. Global Nanostructured Drug Sales (K MT) Forecast by Region (2023-2028) Table 9. Global Nanostructured Drug Sales Market Share Forecast by Region (2023-2028) Table 10. Global Nanostructured Drug Revenue (US$ Million) Forecast by Region (2023-2028) Table 11. Global Nanostructured Drug Revenue Share Forecast by Region (2023-2028) Table 12. Global Nanostructured Drug Sales by Company (K MT) & (2017-2022) Table 13. Global Nanostructured Drug Sales Share by Company (2017-2022) Table 14. Global Nanostructured Drug Revenue by Company (US$ Million) & (2017-2022) Table 15. Global Nanostructured Drug Revenue Share by Company (2017-2022) Table 16. Global Nanostructured Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanostructured Drug as of 2021) Table 17. Global Market Nanostructured Drug Average Price by Company (USD/MT) & (2017-2022) Table 18. Manufacturers Nanostructured Drug Manufacturing Sites and Area Served Table 19. Manufacturers Nanostructured Drug Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 22. Global Nanostructured Drug Sales Share by Type (2017-2022) Table 23. Global Nanostructured Drug Revenue Market Share by Type (2017-2022) & (US$ Million) Table 24. Global Nanostructured Drug Price by Type (2017-2022) & (USD/MT) Table 25. Global Nanostructured Drug Sales Share by Type (2023-2028) Table 26. Global Nanostructured Drug Revenue Market Share by Type (2023-2028) & (US$ Million) Table 27. Global Nanostructured Drug Revenue Share by Type (2023-2028) Table 28. Global Nanostructured Drug Price by Type (2023-2028) & (USD/MT) Table 29. Global Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 30. Global Nanostructured Drug Sales Share by Application (2017-2022) Table 31. Global Nanostructured Drug Revenue Market Share by Application (2017-2022) & (US$ Million) Table 32. Global Nanostructured Drug Price by Application (2017-2022) & (USD/MT) Table 33. Global Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 34. Global Nanostructured Drug Sales Share by Application (2023-2028) Table 35. Global Nanostructured Drug Revenue Market Share by Application (2023-2028) & (US$ Million) Table 36. Global Nanostructured Drug Revenue Share by Application (2023-2028) Table 37. Global Nanostructured Drug Price by Application (2023-2028) & (USD/MT) Table 38. United States Nanostructured Drug Sales by Company (2017-2022) & (K MT) Table 39. United States Nanostructured Drug Sales Market Share by Company (2017-2022) Table 40. United States Nanostructured Drug Revenue by Company (2017-2022) & (US$ Million) Table 41. United States Nanostructured Drug Revenue Market Share by Company (2017-2022) Table 42. United States Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 43. United States Nanostructured Drug Sales Market Share by Type (2017-2022) Table 44. United States Nanostructured Drug Sales by Type (2023-2028) & (K MT) Table 45. United States Nanostructured Drug Sales Market Share by Type (2023-2028) Table 46. United States Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 47. United States Nanostructured Drug Sales Market Share by Application (2017-2022) Table 48. United States Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 49. United States Nanostructured Drug Sales Market Share by Application (2023-2028) Table 50. Europe Nanostructured Drug Sales by Company (2017-2022) & (K MT) Table 51. Europe Nanostructured Drug Sales Market Share by Company (2017-2022) Table 52. Europe Nanostructured Drug Revenue by Company (2017-2022) & (US$ Million) Table 53. Europe Nanostructured Drug Revenue Market Share by Company (2017-2022) Table 54. Europe Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 55. Europe Nanostructured Drug Sales Market Share by Type (2017-2022) Table 56. Europe Nanostructured Drug Sales by Type (2023-2028) & (K MT) Table 57. Europe Nanostructured Drug Sales Market Share by Type (2023-2028) Table 58. Europe Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 59. Europe Nanostructured Drug Sales Market Share by Application (2017-2022) Table 60. Europe Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 61. Europe Nanostructured Drug Sales Market Share by Application (2023-2028) Table 62. China Nanostructured Drug Sales by Company (2017-2022) & (K MT) Table 63. China Nanostructured Drug Sales Market Share by Company (2017-2022) Table 64. China Nanostructured Drug Revenue by Company (2017-2022) & (US$ Million) Table 65. China Nanostructured Drug Revenue Market Share by Company (2017-2022) Table 66. China Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 67. China Nanostructured Drug Sales Market Share by Type (2017-2022) Table 68. China Nanostructured Drug Sales by Type (2023-2028) & (K MT) Table 69. China Nanostructured Drug Sales Market Share by Type (2023-2028) Table 70. China Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 71. China Nanostructured Drug Sales Market Share by Application (2017-2022) Table 72. China Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 73. China Nanostructured Drug Sales Market Share by Application (2023-2028) Table 74. Japan Nanostructured Drug Sales by Company (2017-2022) & (K MT) Table 75. Japan Nanostructured Drug Sales Market Share by Company (2017-2022) Table 76. Japan Nanostructured Drug Revenue by Company (2017-2022) & (US$ Million) Table 77. Japan Nanostructured Drug Revenue Market Share by Company (2017-2022) Table 78. Japan Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 79. Japan Nanostructured Drug Sales Market Share by Type (2017-2022) Table 80. Japan Nanostructured Drug Sales by Type (2023-2028) & (K MT) Table 81. Japan Nanostructured Drug Sales Market Share by Type (2023-2028) Table 82. Japan Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 83. Japan Nanostructured Drug Sales Market Share by Application (2017-2022) Table 84. Japan Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 85. Japan Nanostructured Drug Sales Market Share by Application (2023-2028) Table 86. Southeast Asia Nanostructured Drug Sales by Company (2017-2022) & (K MT) Table 87. Southeast Asia Nanostructured Drug Sales Market Share by Company (2017-2022) Table 88. Southeast Asia Nanostructured Drug Revenue by Company (2017-2022) & (US$ Million) Table 89. Southeast Asia Nanostructured Drug Revenue Market Share by Company (2017-2022) Table 90. Southeast Asia Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 91. Southeast Asia Nanostructured Drug Sales Market Share by Type (2017-2022) Table 92. Southeast Asia Nanostructured Drug Sales by Type (2023-2028) & (K MT) Table 93. Southeast Asia Nanostructured Drug Sales Market Share by Type (2023-2028) Table 94. Southeast Asia Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 95. Southeast Asia Nanostructured Drug Sales Market Share by Application (2017-2022) Table 96. Southeast Asia Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 97. Southeast Asia Nanostructured Drug Sales Market Share by Application (2023-2028) Table 98. India Nanostructured Drug Sales by Company (2017-2022) & (K MT) Table 99. India Nanostructured Drug Sales Market Share by Company (2017-2022) Table 100. India Nanostructured Drug Revenue by Company (2017-2022) & (US$ Million) Table 101. India Nanostructured Drug Revenue Market Share by Company (2017-2022) Table 102. India Nanostructured Drug Sales by Type (2017-2022) & (K MT) Table 103. India Nanostructured Drug Sales Market Share by Type (2017-2022) Table 104. India Nanostructured Drug Sales by Type (2023-2028) & (K MT) Table 105. India Nanostructured Drug Sales Market Share by Type (2023-2028) Table 106. India Nanostructured Drug Sales by Application (2017-2022) & (K MT) Table 107. India Nanostructured Drug Sales Market Share by Application (2017-2022) Table 108. India Nanostructured Drug Sales by Application (2023-2028) & (K MT) Table 109. India Nanostructured Drug Sales Market Share by Application (2023-2028) Table 110. Merck Corporation Information Table 111. Merck Description and Business Overview Table 112. Merck Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 113. Merck Nanostructured Drug Product Table 114. Merck Recent Development Table 115. Pfizer Corporation Information Table 116. Pfizer Description and Business Overview Table 117. Pfizer Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 118. Pfizer Nanostructured Drug Product Table 119. Pfizer Recent Development Table 120. Novartis Corporation Information Table 121. Novartis Description and Business Overview Table 122. Novartis Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 123. Novartis Nanostructured Drug Product Table 124. Novartis Recent Development Table 125. Abbott Corporation Information Table 126. Abbott Description and Business Overview Table 127. Abbott Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 128. Abbott Nanostructured Drug Product Table 129. Abbott Recent Development Table 130. GlaxoSmithKline Corporation Information Table 131. GlaxoSmithKline Description and Business Overview Table 132. GlaxoSmithKline Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 133. GlaxoSmithKline Nanostructured Drug Product Table 134. GlaxoSmithKline Recent Development Table 135. Roche Corporation Information Table 136. Roche Description and Business Overview Table 137. Roche Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 138. Roche Nanostructured Drug Product Table 139. Roche Recent Development Table 140. Sanofi Corporation Information Table 141. Sanofi Description and Business Overview Table 142. Sanofi Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 143. Sanofi Nanostructured Drug Product Table 144. Sanofi Recent Development Table 145. Eli Lilly Corporation Information Table 146. Eli Lilly Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 147. Eli Lilly Description and Business Overview Table 148. Eli Lilly Nanostructured Drug Product Table 149. Eli Lilly Recent Development Table 150. Astrazeneca Corporation Information Table 151. Astrazeneca Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 152. Astrazeneca Description and Business Overview Table 153. Astrazeneca Nanostructured Drug Product Table 154. Astrazeneca Recent Development Table 155. Johnson & Johnson Corporation Information Table 156. Johnson & Johnson Description and Business Overview Table 157. Johnson & Johnson Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 158. Johnson & Johnson Nanostructured Drug Product Table 159. Johnson & Johnson Recent Development Table 160. Celgene Corporation Information Table 161. Celgene Description and Business Overview Table 162. Celgene Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 163. Celgene Nanostructured Drug Product Table 164. Celgene Recent Development Table 165. Novavax Corporation Information Table 166. Novavax Description and Business Overview Table 167. Novavax Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 168. Novavax Nanostructured Drug Product Table 169. Novavax Recent Development Table 170. Stryker Corporation Information Table 171. Stryker Description and Business Overview Table 172. Stryker Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 173. Stryker Nanostructured Drug Product Table 174. Stryker Recent Development Table 175. Gilead Sciences Corporation Information Table 176. Gilead Sciences Description and Business Overview Table 177. Gilead Sciences Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 178. Gilead Sciences Nanostructured Drug Product Table 179. Gilead Sciences Recent Development Table 180. OSI Pharmaceuticals Corporation Information Table 181. OSI Pharmaceuticals Description and Business Overview Table 182. OSI Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 183. OSI Pharmaceuticals Nanostructured Drug Product Table 184. OSI Pharmaceuticals Recent Development Table 185. Kadmon Pharmaceuticals Corporation Information Table 186. Kadmon Pharmaceuticals Description and Business Overview Table 187. Kadmon Pharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 188. Kadmon Pharmaceuticals Nanostructured Drug Product Table 189. Kadmon Pharmaceuticals Recent Development Table 190. Samyang Biopharm Corporation Information Table 191. Samyang Biopharm Description and Business Overview Table 192. Samyang Biopharm Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 193. Samyang Biopharm Nanostructured Drug Product Table 194. Samyang Biopharm Recent Development Table 195. Mitsubishi Pharma Corporation Information Table 196. Mitsubishi Pharma Description and Business Overview Table 197. Mitsubishi Pharma Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 198. Mitsubishi Pharma Nanostructured Drug Product Table 199. Mitsubishi Pharma Recent Development Table 200. Kaken Pharmaceutical Corporation Information Table 201. Kaken Pharmaceutical Description and Business Overview Table 202. Kaken Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 203. Kaken Pharmaceutical Nanostructured Drug Product Table 204. Kaken Pharmaceutical Recent Development Table 205. Selecta Biosciences Corporation Information Table 206. Selecta Biosciences Description and Business Overview Table 207. Selecta Biosciences Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 208. Selecta Biosciences Nanostructured Drug Product Table 209. Selecta Biosciences Recent Development Table 210. Par Pharmaceutical Corporation Information Table 211. Par Pharmaceutical Description and Business Overview Table 212. Par Pharmaceutical Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 213. Par Pharmaceutical Nanostructured Drug Product Table 214. Par Pharmaceutical Recent Development Table 215. Cerulean Pharma Corporation Information Table 216. Cerulean Pharma Description and Business Overview Table 217. Cerulean Pharma Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 218. Cerulean Pharma Nanostructured Drug Product Table 219. Cerulean Pharma Recent Development Table 220. Navidea Biopharmaceuticals Corporation Information Table 221. Navidea Biopharmaceuticals Description and Business Overview Table 222. Navidea Biopharmaceuticals Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 223. Navidea Biopharmaceuticals Nanostructured Drug Product Table 224. Navidea Biopharmaceuticals Recent Development Table 225. Lummy Corporation Information Table 226. Lummy Description and Business Overview Table 227. Lummy Nanostructured Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 228. Lummy Nanostructured Drug Product Table 229. Lummy Recent Development Table 230. Production Base and Market Concentration Rate of Raw Material Table 231. Key Suppliers of Raw Materials Table 232. Nanostructured Drug Distributors List Table 233. Nanostructured Drug Customers List Table 234. Nanostructured Drug Market Trends Table 235. Nanostructured Drug Market Drivers Table 236. Nanostructured Drug Market Challenges Table 237. Nanostructured Drug Market Restraints Table 238. Research Programs/Design for This Report Table 239. Key Data Information from Secondary Sources Table 240. Key Data Information from Primary Sources List of Figures Figure 1. Nanostructured Drug Product Picture Figure 2. Global Nanostructured Drug Sales Market Share by Type in 2021 & 2028 Figure 3. Liposomes Product Picture Figure 4. Polymeric Micelles Product Picture Figure 5. Solid lipid Nanoparticles Product Picture Figure 6. Microemulsion and Nanoemulsion Product Picture Figure 7. Nanosuspension Product Picture Figure 8. Global Nanostructured Drug Sales Market Share by Application in 2021 & 2028 Figure 9. Cancer and Tumors Examples Figure 10. Autoimmune Disorders Examples Figure 11. Global Nanostructured Drug Sales, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Nanostructured Drug Sales Growth Rate (2017-2028) & (US$ Million) Figure 13. Global Nanostructured Drug Sales (K MT) Growth Rate (2017-2028) Figure 14. Global Nanostructured Drug Price Trends Growth Rate (2017-2028) & (USD/MT) Figure 15. Global Nanostructured Drug Revenue Market Share by Region: 2021 VS 2028 Figure 16. United States Nanostructured Drug Revenue (US$ Million) Growth Rate (2017-2028) Figure 17. United States Nanostructured Drug Sales (K MT) Growth Rate (2017-2028) Figure 18. Europe Nanostructured Drug Revenue (US$ Million) Growth Rate (2017-2028) Figure 19. Europe Nanostructured Drug Sales (US$ Million) Growth Rate (2017-2028) Figure 20. China Nanostructured Drug Revenue (US$ Million) Growth Rate (2017-2028) Figure 21. China Nanostructured Drug Sales (US$ Million) and Growth Rate (2017-2028) Figure 22. Japan Nanostructured Drug Revenue (US$ Million) Growth Rate (2017-2028) Figure 23. Japan Nanostructured Drug Sales (US$ Million) Growth Rate (2017-2028) Figure 24. Southeast Asia Nanostructured Drug Revenue (US$ Million) Growth Rate (2017-2028) Figure 25. Southeast Asia Nanostructured Drug Sales (US$ Million) Growth Rate (2017-2028) Figure 26. India Nanostructured Drug Revenue (US$ Million) Growth Rate (2017-2028) Figure 27. India Nanostructured Drug Sales (US$ Million) Growth Rate (2017-2028) Figure 28. Global 5 Largest Nanostructured Drug Players Market Share by Revenue in Nanostructured Drug: 2017 & 2021 Figure 29. Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 30. Global Nanostructured Drug Revenue Share by Type (2017-2022) Figure 31. Global Nanostructured Drug Revenue Share by Application (2017-2022) Figure 32. Global Nanostructured Drug Revenue Growth Rate by Application in 2017 & 2021 Figure 33. United States Nanostructured Drug Sales Market Share by Type in 2021 Figure 34. United States Nanostructured Drug Sales Market Share by Application in 2021 Figure 35. Europe Nanostructured Drug Sales Market Share by Type in 2021 Figure 36. Europe Nanostructured Drug Sales Market Share by Application in 2021 Figure 37. China Nanostructured Drug Sales Market Share by Type in 2021 Figure 38. China Nanostructured Drug Sales Market Share by Application in 2021 Figure 39. Japan Nanostructured Drug Sales Market Share by Type in 2021 Figure 40. Japan Nanostructured Drug Sales Market Share by Application in 2021 Figure 41. Southeast Asia Nanostructured Drug Sales Market Share by Type in 2021 Figure 42. Southeast Asia Nanostructured Drug Sales Market Share by Application in 2021 Figure 43. India Nanostructured Drug Sales Market Share by Type in 2021 Figure 44. India Nanostructured Drug Sales Market Share by Application in 2021 Figure 45. Key Raw Materials Price Trend Figure 46. Manufacturing Cost Structure of Nanostructured Drug Figure 47. Manufacturing Process Analysis of Nanostructured Drug Figure 48. Nanostructured Drug Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Merck Pfizer Novartis Abbott GlaxoSmithKline Roche Sanofi Eli Lilly Astrazeneca Johnson & Johnson Celgene Novavax Stryker Gilead Sciences OSI Pharmaceuticals Kadmon Pharmaceuticals Samyang Biopharm Mitsubishi Pharma Kaken Pharmaceutical Selecta Biosciences Par Pharmaceutical Cerulean Pharma Navidea Biopharmaceuticals Lummy